Respiratory Virus News and Research

RSS

Alveolar macrophages present as antigens to promote virus-specific CD8+ T cell expansion

The human immune system is a highly complex network of cells, signals, and responses that is tightly regulated to ensure that the body can fight off infection without damaging its own tissues.

28 Dec 2022

UK government strikes a deal with Moderna to boost mRNA research and development

Patients in the UK will be protected against potential future global health threats, including potential pandemics, thanks to a deal struck between the government and Moderna.

22 Dec 2022

Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding

A study describes the antiviral activity of flavor/fragrance compositions against SARS-CoV-2.

20 Dec 2022

Seasonal influenza activity remains high but appears to be declining in some areas of the US

The weekly FluView Report mentions that the number of influenza cases seems to be declining in some areas in the United States. However, the overall seasonal influenza activity remains high.

19 Dec 2022

COVID-19 vaccines may reduce long-COVID symptoms

A new study describes the effectiveness of coronavirus disease 2019 (COVID-19) vaccines in reducing long-COVID symptoms.

8 Dec 2022

Wearing glasses does not reduce risk of COVID-19

A new study determines the impact of wearing glasses on the risk of infection with SARS-CoV-2 and other respiratory viruses.

5 Dec 2022

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients

A prospective, randomized, open-level clinical trial demonstrates that gargling with povidone-iodine accelerates viral clearance and reduces saliva infectivity in patients with asymptomatic or mild coronavirus disease 2019 (COVID-19). The trial findings have been published in the journal Scientific Reports.

1 Dec 2022

How lessons from the HIV epidemic can help combat COVID-19

Researchers revisit lessons learned from the HIV pandemic in response to COVID-19.

13 Nov 2022

Surge in RSV cases – how worried should you be?

RSV hospitalizations are reaching similarly high levels much earlier than normal this year.

10 Nov 2022

RSV and kids: What you need to know

An overview on the prevalence, symptoms, and management of RSV in children.

2 Nov 2022

Nebulized mRNA-encoded antibodies found to protect hamsters against COVID-19

New research describes a novel route of prevention, using messenger ribonucleic acid (mRNA) molecules that encode protective antibodies within the recipient.

2 Nov 2022

Scientists discover a promising strategy for development of broad-spectrum antiviral therapies

Researchers have identified a promising strategy for development of broad-spectrum antiviral therapies that centers around promoting a strong immune response capable of stopping a number of viruses in their infectious tracks.

10 Oct 2022

Evaluating graphene field effect biosensor for ultraprecise and simultaneous influenza and SARS-CoV-2 detection

In a new study, researchers developed an antibody (Ab)-modified graphene field effect transistor (GFET)-based biosensor for ultraprecise and rapid influenza A virus (IAV) and SARS-CoV-2 protein detection and differentiation.

10 Oct 2022

Chronic liver disease in COVID-19 patients

A recent study summarizes the clinical outcomes of COVID-19 patients with chronic liver disease.

10 Oct 2022

Can a commercial breath analysis test detect SARS-CoV-2?

Researchers demonstrated the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by a commercial breath analysis test (BAT).

22 Sep 2022

Highly sensitive mask can detect respiratory viruses in the air within 10 minutes

Scientists have created a face mask that can detect common respiratory viruses, including influenza and the coronavirus, in the air in droplets or aerosols.

19 Sep 2022

Can preclinical COVID-19 models help unlock mystery of long-COVID?

In a recently published article in the journal PLOS PATHOGENS, scientists have summarized acute and prolonged clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The review also provides an overview of the potency and utility of preclinical animal models to understand the mechanistic details of acute and long coronavirus disease 2019 (COVID-19).

8 Sep 2022

Respiratory Virus News and Research

Alveolar macrophages present as antigens to promote virus-specific CD8+ T cell expansion

UK government strikes a deal with Moderna to boost mRNA research and development

Study finds several flavor/fragrance compositions that inhibit vRBD-hACE2 binding

Seasonal influenza activity remains high but appears to be declining in some areas of the US

COVID-19 vaccines may reduce long-COVID symptoms

Wearing glasses does not reduce risk of COVID-19

Gargling with povidone-iodine may reduce salivary viral load in COVID-19 patients

How lessons from the HIV epidemic can help combat COVID-19

Surge in RSV cases – how worried should you be?

RSV and kids: What you need to know

Nebulized mRNA-encoded antibodies found to protect hamsters against COVID-19

Scientists discover a promising strategy for development of broad-spectrum antiviral therapies

Evaluating graphene field effect biosensor for ultraprecise and simultaneous influenza and SARS-CoV-2 detection

Chronic liver disease in COVID-19 patients

Can a commercial breath analysis test detect SARS-CoV-2?

Highly sensitive mask can detect respiratory viruses in the air within 10 minutes

Can preclinical COVID-19 models help unlock mystery of long-COVID?

Universal benefits of positive psychological factors may not generalize across races, study suggests

Smoking and the risk of contracting SARS-CoV-2 and COVID-19

Single-dose therapeutic interfering particle lowers SARS-CoV-2 pathogenesis and shedding among hamsters

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News